Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1131321

registered interest
date	11/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress he has made on ensuring that medical cannabis is available to people who need it.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	263063
answer	answer is ministerial correction date of answer 19/06/2019 answer text <p>The law was changed on 1 November 2018 to allow clinicians on the General Medical Council’s ‘Specialist Register’ to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interest of patients.</p><p>Interim clinical guidance has been issued by the Royal College of Physicians, the British Paediatric Neurology Association and the Association of British Neurologists to support doctors looking to prescribe cannabis-based products. The National Institute for Health and Care Excellence (NICE) has been commissioned to develop updated clinical guidance on the prescribing of cannabis-based medicinal products, which will be published by October 2019. It will be based on the best available international evidence and will have been produced using NICE’s world-renowned process for delivering such guidance.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 19/06/2019 14:21:18 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead

1128815

registered interest
date	03/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that all patients who would benefit from medical cannabis are able to access that treatment on prescription on the NHS.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	259011
answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Cannabis-based products for medicinal use are no different from other medicines, and existing systems for the funding of both licensed and unlicensed medicines apply.</p><p>Any medicines which receive a marketing authorisation from the Medicines and Healthcare Products Regulatory Agency or European Medicines Agency will be assessed for cost effectiveness by the National Institute for Health and Care Excellence. This is the foundation of National Health Service decisions about routine funding, and applies to all licensed medicines. For unlicensed medicines, the normal NHS medicines governance systems apply, as they do to all locally funded unlicensed treatments. These processes support good clinical practice and safe and effective prescribing. Decisions will be taken, at NHS Trust level on a case by case basis, based on the needs of the individual patient and the evidence of efficacy and cost effectiveness available.</p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care has heard patients report difficulties in accessing medicinal cannabis. As a result, he asked the Department to work closely with NHS England to undertake a rapid process evaluation. This is underway and will review NHS system processes to identify and make recommendations to address any barriers to clinically appropriate prescribing, should they exist.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 11/06/2019 16:52:22 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead

1128572

registered interest
date	23/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Health: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the level of child tooth decay was in (a) Birkenhead, (b) Bootle and (c) Crewe in each of the last five years for which data is available.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	257654
answer	answer is ministerial correction date of answer 05/06/2019 answer text <p>Data on the level of child tooth decay in five-year-old children are published at upper and lower-tier local authority level and, therefore, are not available in the format requested.</p><p>Local authority data for 2014/15 and 2016/17 is available at the following link:</p><p><a href="https://www.gov.uk/government/statistics/oral-health-survey-of-5-year-old-children-2014-to-2015" target="_blank">https://www.gov.uk/government/statistics/oral-health-survey-of-5-year-old-children-2014-to-2015</a></p><p><a href="https://www.gov.uk/government/statistics/oral-health-survey-of-5-year-old-children-2017" target="_blank">https://www.gov.uk/government/statistics/oral-health-survey-of-5-year-old-children-2017</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 05/06/2019 15:18:45 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead

1127581

registered interest
date	20/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cystic Fibrosis: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the conclusion of negotiations between NHS England, NICE and Vertex on access to (a) Orkambi and (b) Symkevi for people with cystic fibrosis.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	256233
answer	answer is ministerial correction date of answer 29/05/2019 answer text <p>NHS England provided an update to the Health and Social Care Committee (HSCC) of the House of Commons on 23 May 2019, which can be found at the following link:</p><p><a href="https://www.parliament.uk/documents/commons-committees/Health/Correspondence/2017-19/19-05-23-NHS-England-update-availability-of-Orkambi-on-the-NHS.pdf" target="_blank">https://www.parliament.uk/documents/commons-committees/Health/Correspondence/2017-19/19-05-23-NHS-England-update-availability-of-Orkambi-on-the-NHS.pdf</a></p><p>This update informed the HSCC that a revised and improved offer had been made to Vertex Pharmaceuticals. Discussions between Vertex, NHS England and the National Institute for Health and Care Excellence (NICE) are ongoing.</p><p>The Government fully supports NICE and NHS England in seeking to ensure access for patients to effective and innovative medicines at a price that represents value to the National Health Service, and expects companies to engage realistically with NHS England and NICE regarding pricing issues. Where companies engage positively and show appropriate flexibility, it is possible to find a way to enable access to important treatments in a way that is also cost effective for the NHS.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 29/05/2019 11:10:57 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead

1126678

registered interest
date	14/05/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timeframe is for NHS prescription forms to be amended to include tick boxes for universal credit.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	254153
answer	answer is ministerial correction date of answer 20/05/2019 answer text <p>A revised version of the FP10 prescription form, featuring a dedicated tick-box for use by Universal Credit claimants who meet the criteria for free National Health Service prescriptions, recently received Ministerial clearance.</p><p> </p><p>Any change involves major system and software updates across the NHS to allow the re-designed form to be used and processed. The revised paper form is currently being prepared for testing, to ensure it is compatible with the scanners used by the NHS Business Services Authority.</p><p> </p><p>The revised form will be introduced at the earliest opportunity.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 20/05/2019 15:59:00 answering member 4455 label Biography information for Seema Kennedy
tabling member	478 label Biography information for Lord Field of Birkenhead